With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Too Old to Operate2d
Glucose-Lowering Mechanisms of PPARG in Diabetic Retinopathy
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
UUHC Health Feed13d
John A. Moran Eye Center Physician Scientists Keeping an Eye on Patients Taking New Class of Diabetes and Weight Loss Drugs
A review of the cases, coupled with the latest research in the field, led the authors to hypothesize that rapid changes ... eye disease in people with Type 2 diabetes. “Because of the association of ...
Medindia4d
Popular Antidiabetic GLP-1 Medications Linked to Rare Vision Loss
Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...
Pharm Exec7d
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...
Keep An Eye On EYPT - Diabetic Macular Edema, Wet AMD Trial Results Awaited
EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...
Endocrinology Advisor6d
Susvimo Approval Expanded to Include Diabetic Macular Edema
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.